-
-
-
-
-
-
-
Taysha Gene Therapies (TSHA) files mixed shelf
-
-
-
-
-
-
-
Cantor Fitzgerald Reiterates Overweight Rating on Taysha Gene Therapies (TSHA)
-
-
-
-
-
-
-
Taysha Gene Therapies (TSHA) announces presentations for TSHA-102 program
-
-
-
-
-
-
-
Taysha Gene Therapies (TSHA) Tops Q1 EPS by 1c
-
-
-
-
-
-
-
Piper Sandler Reiterates Overweight Rating on Taysha Gene Therapies (TSHA)
-
-
-
-
-
-
-
Taysha Gene Therapies (TSHA) Prices 14.36M Share and Warrant Offering at $2.25/sh
-
-
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

